ResMed Inc. (RMD) Q1 2027 Earnings Call Transcript

ResMed Inc. (RMD) Q1 2027 Earnings Call Transcript

Seeking Alpha • an hour ago

Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2027

Note: A webcast of Resmed's conference call will be available at 4:30 p.m. ET today at  http://investor.resmed.com

GlobeNewsWire • 6 hours ago

ResMed (RMD) Beats Q1 Earnings and Revenue Estimates

ResMed (RMD) came out with quarterly earnings of $2.91 per share, beating the Zacks Consensus Estimate of $2.67 per share. This compares to earnings of $2.55 per share a year ago.

Zacks Investment Research • 3 hours ago

Here's Why ResMed (RMD) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • 11 hours ago

Unlocking Q1 Potential of ResMed (RMD): Exploring Wall Street Estimates for Key Metrics

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for ResMed (RMD), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2026.

Zacks Investment Research • Oct 28, 2026

ResMed Set to Report Q1 Earnings: What's in the Cards for the Stock?

RMD heads into Q1 fiscal 2027 earnings with sleep device demand and new product launches supporting growth, while MatrixCare's divestiture weighs on revenues.

Zacks Investment Research • Oct 23, 2026

Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report?

ResMed (RMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Investment Research • Oct 23, 2026

ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

ResMed (RMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research • Oct 22, 2026

Resmed Launches AirTouch™ F40 Full Face Fabric CPAP Mask in the U.S.

SAN DIEGO, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced the U.S. launch of AirTouch F40, the newest addition to its growing portfolio of fabric continuous positive airway pressure (CPAP) masks. Designed for people with obstructive sleep apnea (OSA) to provide greater comfort and choice in therapy1, the AirTouch F40 helps address key factors that can influence long-term adherence.

GlobeNewsWire • Oct 19, 2026

Big tech is wobbling. Goldman Sachs says it's time to buy these 23 unloved stocks instead.

Goldman Sachs says consumer-facing laggard stocks are the best way forward as earnings growth is set to slow next year and big tech stocks struggle.

Market Watch • Oct 19, 2026